Related Experiment Videos

[Liver disease in systemic lupus erythematosus]

A Suzuki1, N Sekiyama, N Koito

  • 1Department of Internal Medicine, Kawasaki Municipal Hospital.

Insights

Systemic lupus erythematosus (SLE) patients frequently experience liver disease, with 40.4% showing abnormal transaminases. While liver issues are common in SLE, severe cases were not observed in this study.

Area of Science:

  • Hepatology
  • Rheumatology
  • Internal Medicine

Context:

  • Systemic lupus erythematosus (SLE) is a chronic autoimmune disease.
  • Liver involvement is a recognized, though less common, manifestation of SLE.
  • Understanding the spectrum of liver disease in SLE patients is crucial for comprehensive patient care.

Purpose:

  • To analyze the prevalence and types of liver disease in patients with systemic lupus erythematosus (SLE).
  • To identify SLE as a potential cause of liver disease in the absence of other identifiable etiologies.
  • To characterize the clinical presentation and severity of liver disease in an SLE cohort.

Summary:

  • A retrospective analysis of 193 patients with SLE revealed abnormal transaminase levels in 40.4% (78 patients).
  • Among these, 35 patients had identified liver diseases, with 12 cases attributed to SLE alone.
  • Other diagnosed liver conditions included fatty liver, viral infections, gallstones, drug allergies, autoimmune hepatitis, and primary biliary cirrhosis; no severe cases were reported.

Impact:

  • Highlights the significant frequency of liver abnormalities in SLE patients.
  • Suggests SLE itself can be an independent cause of liver disease.
  • Indicates that while liver disease is common in SLE, it may often present in a non-severe form.

Related Concept Videos